{"content":"<li class=\"n-box-item date-title\" data-end=\"1370404799\" data-start=\"1370318400\" data-txt=\"Friday, December 20, 2019\">Tuesday, June  4, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1064631\" data-ts=\"1370390263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064631\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Ambarella (NASDAQ:AMBA): Q1 easily beats across the board as total sales jump by 30%...</a></h4><p>More on Ambarella (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMBA\" title=\"Ambarella\">AMBA</a>): <a href=\"https://seekingalpha.com/market_currents/post/1064201\" target=\"_blank\">Q1 easily beats</a> across the board as total sales jump by 30% from the prior year. Net profit soared 82% on strong growth in its Internet-protocol security camera and wearable sports camera markets. Gross margin narrowed however, to 63.9% from 71%, as input costs jumped 63%. Shares <font color=\"green\">+10.8%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1064631\" data-linked=\"More on Ambarella (NASDAQ:AMBA): Q1 easily beats across the board as total sales jump by 30%...\" data-tweet=\"$AMBA - More on Ambarella (NASDAQ:AMBA): Q1 easily beats across the board as total sales jump by 30% from the prior year. Net profit soared 82% on strong growth in its Internet-protocol security camera and wearable sports camera markets. Gross margin na... https://seekingalpha.com/news/1064631?source=tweet\" data-url=\"https://seekingalpha.com/news/1064631\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064621\" data-ts=\"1370389645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHFL\" target=\"_blank\">SHFL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064621\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on SHFL Entertainment (NASDAQ:SHFL): FQ2 beats both EPS and revenue estimates. Net profit...</a></h4><p>More on SHFL Entertainment (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SHFL\" title=\"SHFL entertainment, Inc.\">SHFL</a>): <a href=\"https://seekingalpha.com/market_currents/post/1064091\" target=\"_blank\">FQ2 beats</a> both EPS and revenue estimates. Net profit rose 22% on record revenue in its slot machine, shuffler, and specialty table games businesses. Its leasing and royalties business saw revenue improve 8.5% to $29.2M, while product sales and service reported 23% higher revenue at $48.2M. Gross margin edged up to 64.7% from 64.3%, as total costs and expenses grew 16% to  $27.3 million. Shares <font color=\"green\">+5.1%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1064621\" data-linked=\"More on SHFL Entertainment (NASDAQ:SHFL): FQ2 beats both EPS and revenue estimates. Net profit...\" data-tweet=\"$SHFL - More on SHFL Entertainment (NASDAQ:SHFL): FQ2 beats both EPS and revenue estimates. Net profit rose 22% on record revenue in its slot machine, shuffler, and specialty table games businesses. Its leasing and royalties business saw revenue improve... https://seekingalpha.com/news/1064621?source=tweet\" data-url=\"https://seekingalpha.com/news/1064621\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064611\" data-ts=\"1370388614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BV-OLD\" target=\"_blank\">BV-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064611\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Bazaarvoice (NASDAQ:BV-OLD): FQ4 beats across the board. Net loss widened however, on...</a></h4>More on Bazaarvoice (NASDAQ:<a href='https://seekingalpha.com/symbol/BV-OLD' title='Bazaarvoice'>BV-OLD</a>): <a href=\"https://seekingalpha.com/market_currents/post/1064111\" target=\"_blank\">FQ4 beats</a> across the board. Net loss widened however, on higher sales and marketing costs and acquisition-related expenses, which masked double-digit revenue growth. Gross margin edged up to 67.3% from 67.2%, although input costs were up 37% and sales and marketing expenses jumped 61%. Shares <font color=\"green\">+4.8%</font> AH.<div class=\"tiny-share-widget\" data-id=\"1064611\" data-linked=\"More on Bazaarvoice (NASDAQ:BV-OLD): FQ4 beats across the board. Net loss widened however, on...\" data-tweet=\"$BV-OLD - More on Bazaarvoice (NASDAQ:BV-OLD): FQ4 beats across the board. Net loss widened however, on higher sales and marketing costs and acquisition-related expenses, which masked double-digit revenue growth. Gross margin edged up to 67.3% from 67.2... https://seekingalpha.com/news/1064611?source=tweet\" data-url=\"https://seekingalpha.com/news/1064611\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064481\" data-ts=\"1370381832\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GA\" target=\"_blank\">GA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064481\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Giant Interactive (NYSE:GA) -5.9% AH after filing to sell 15.1M shares (6.3% of outstanding...</a></h4><p>Giant Interactive (NYSE:<a href=\"https://seekingalpha.com/symbol/GA\" title=\"Giant Interactive Group Inc.\">GA</a>) <font color=\"red\">-5.9%</font> AH after filing to sell 15.1M shares (6.3% of outstanding shares) on behalf of a Virgin Islands-based holdings company owned by founder/chairman Yuzhu Shi's daughter. Following the offering, Shi's effective ownership stake in Giant will fall to 48.5% from 54.8%. News of the offering comes with shares of the Chinese game developer having <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1369944000000&amp;chddm=481798&amp;chls=IntervalBasedLine&amp;q=NYSE:GA&amp;ntsp=0&amp;ei=Q1uuUZjZM-KviAK3uAE\" target=\"_blank\">closed near multi-year highs</a>. (<a href=\"http://www.sec.gov/Archives/edgar/data/1415016/000119312513247048/d549247d424b5.htm\" target=\"_blank\">prospectus</a>)</p><div class=\"tiny-share-widget\" data-id=\"1064481\" data-linked=\"Giant Interactive (NYSE:GA) -5.9% AH after filing to sell 15.1M shares (6.3% of outstanding...\" data-tweet=\"$GA - Giant Interactive (NYSE:GA) -5.9% AH after filing to sell 15.1M shares (6.3% of outstanding shares) on behalf of a Virgin Islands-based holdings company owned by founder/chairman Yuzhu Shi&#39;s daughter. Following the offering, Shi&#39;s effective owners... https://seekingalpha.com/news/1064481?source=tweet\" data-url=\"https://seekingalpha.com/news/1064481\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064461\" data-ts=\"1370381425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064461\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 5:15 p.m.: AMBA +9%. SHFL +5%. MFRM +5%. BOBE +4%. PKD-OLD +3%....</a></h4><b>After-hours top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a> <font color=\"green\">+9%</font>. <a href='https://seekingalpha.com/symbol/SHFL' title='SHFL entertainment, Inc.'>SHFL</a> <font color=\"green\">+5%</font>. <a href='https://seekingalpha.com/symbol/MFRM' title='Mattress Firm Holding Corp.'>MFRM</a> <font color=\"green\">+5%</font>. <a href='https://seekingalpha.com/symbol/BOBE' title='Bob Evans Farms, Inc.'>BOBE</a> <font color=\"green\">+4%</font>. <a href='https://seekingalpha.com/symbol/PKD-OLD' title='Parker Drilling Company'>PKD-OLD</a> <font color=\"green\">+3%</font>. <br /><b>After-hours top losers:</b> <a href='https://seekingalpha.com/symbol/FRA' title='BlackRock Floating Rate Income Strategies Fund'>FRA</a> <font color=\"red\">-3%</font>. <a href='https://seekingalpha.com/symbol/PBF' title='PBF Energy'>PBF</a> <font color=\"red\">-2%</font>. <a href='https://seekingalpha.com/symbol/SXCP' title='SunCoke Energy Partners'>SXCP</a> <font color=\"red\">-1%</font>. <a href='https://seekingalpha.com/symbol/JHS' title='John Hancock Income Securities Trust'>JHS</a> <font color=\"red\">-1%</font>. <a href='https://seekingalpha.com/symbol/WMK' title='Weis Markets Inc'>WMK</a> <font color=\"red\">-1%</font>.<div class=\"tiny-share-widget\" data-id=\"1064461\" data-linked=\"After-hours top gainers, as of 5:15 p.m.: AMBA +9%. SHFL +5%. MFRM +5%. BOBE +4%. PKD-OLD +3%....\" data-tweet=\"$AMBA $AMBA $SHFL - After-hours top gainers, as of 5:15 p.m.: AMBA +9%. SHFL +5%. MFRM +5%. BOBE +4%. PKD-OLD +3%. After-hours top losers: FRA -3%. PBF -2%. SXCP -1%. JHS -1%. WMK -1%. https://seekingalpha.com/news/1064461?source=tweet\" data-url=\"https://seekingalpha.com/news/1064461\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064431\" data-ts=\"1370380628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOBE\" target=\"_blank\">BOBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064431\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Bob Evans (NASDAQ:BOBE): FQ4 earnings beat across the board. Net profit jumped 23% Y/Y...</a></h4><p>More on Bob Evans (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BOBE\" title=\"Bob Evans Farms, Inc.\">BOBE</a>): <a href=\"https://seekingalpha.com/market_currents/post/1064261\" target=\"_blank\">FQ4 earnings</a> beat across the board. Net profit jumped 23% Y/Y due to a tax benefit, which masked losses related to the sale of its Mimi's Cafe franchise and weaker overall revenue. Same-store sales edged up 0.5% at its namesake restaurants, though overall sales were down 1.3%. Looking forward, the company lowered earnings guidance for the new fiscal year. It now expects to earn between $2.60 to $2.67, below Street estimates for  $2.71. Shares <font color=\"green\">+3.9%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1064431\" data-linked=\"More on Bob Evans (NASDAQ:BOBE): FQ4 earnings beat across the board. Net profit jumped 23% Y/Y...\" data-tweet=\"$BOBE - More on Bob Evans (NASDAQ:BOBE): FQ4 earnings beat across the board. Net profit jumped 23% Y/Y due to a tax benefit, which masked losses related to the sale of its Mimi&#39;s Cafe franchise and weaker overall revenue. Same-store sales edged up 0.5% ... https://seekingalpha.com/news/1064431?source=tweet\" data-url=\"https://seekingalpha.com/news/1064431\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064421\" data-ts=\"1370380384\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MFRM\" target=\"_blank\">MFRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064421\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Mattress Firm&#39;s (NASDAQ:MFRM) Q1: A 31.5% increase in quarterly revenue reflects...</a></h4><p>More on Mattress Firm's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MFRM\" title=\"Mattress Firm Holding Corp.\">MFRM</a>) <a href=\"https://seekingalpha.com/currents/post/1064161\" target=\"_blank\">Q1</a>: A 31.5% increase in quarterly revenue reflects \"incremental sales from new and acquired stores,\" partially offset by negative comps growth (-5.2%). 46 new stores were opened during the quarter. Operating margin falls 50 basis points to 8.6%. The company reaffirms its full year guidance of $1.90-1.98/share (adjusted) on $1.237-1.25B in revenue versus consensus of $1.96/share on $1.23B in sales. Shares <font color=\"green\">+6.5%</font>. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1064421\" data-linked=\"More on Mattress Firm&#39;s (NASDAQ:MFRM) Q1: A 31.5% increase in quarterly revenue reflects...\" data-tweet=\"$MFRM - More on Mattress Firm&#39;s (NASDAQ:MFRM) Q1: A 31.5% increase in quarterly revenue reflects &quot;incremental sales from new and acquired stores,&quot; partially offset by negative comps growth (-5.2%). 46 new stores were opened during the quarter. Operating... https://seekingalpha.com/news/1064421?source=tweet\" data-url=\"https://seekingalpha.com/news/1064421\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064411\" data-ts=\"1370379947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064411\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wix, a top provider of web site development tools/templates and hosting services for consumers...</a></h4><p>Wix, a top provider of web site development <a target=\"_blank\" href=\"http://www.wix.com/about/features\">tools/templates</a> and hosting services for consumers and small businesses, has confidentially <a target=\"_blank\" href=\"http://techcrunch.com/2013/06/04/now-27m-users-strong-diy-web-publishing-platform-wix-takes-its-first-step-toward-ipo/\">filed for an IPO</a> - <em>Globes</em> claims the Israel-based company is <a target=\"_blank\" href=\"http://www.globes.co.il/serveen/globes/docview.asp?did=1000849672\">looking to raise $75M</a> at a $400M valuation. Wix claims 31.5M sites have been built using its tools, generates revenue by <a target=\"_blank\" href=\"http://www.wix.com/upgrade/website\">selling premium plans</a> that offer features such as extra storage and bandwidth. The company launched an <a target=\"_blank\" href=\"http://techcrunch.com/2012/10/16/wix-app-market/\">app market</a> and mobile-friendly HTML5 tools last year.</p><div class=\"tiny-share-widget\" data-id=\"1064411\" data-linked=\"Wix, a top provider of web site development tools/templates and hosting services for consumers...\" data-tweet=\"Wix, a top provider of web site development tools/templates and hosting services for consumers and small businesses, has confidentially filed for an IPO - Globes claims the Israel-based company is looking to raise $75M at a $400M valuation. Wix claims 3... https://seekingalpha.com/news/1064411?source=tweet\" data-url=\"https://seekingalpha.com/news/1064411\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064241\" data-ts=\"1370378082\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MIND\" target=\"_blank\">MIND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064241\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Mitcham Industries (NASDAQ:MIND): Q1 earnings miss across the board. Net profit fell 25%...</a></h4><p>More on Mitcham Industries (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MIND\" title=\"Mitcham Industries, Inc.\">MIND</a>): <a href=\"https://seekingalpha.com/market_currents/post/1064191\" target=\"_blank\">Q1 earnings</a> miss across the board. Net profit fell 25% Y/Y as the seismic-equipment supplier posted weaker revenue, although margins improved to 53.5% from 48.8% on a 28% decline in input costs. Equipment-leasing revenue, its biggest top-line contributor, slipped 4.4% on continued softness in land leasing activity and a temporary slowdown in marine leasing. Shares <font color=\"red\">-1.4%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1064241\" data-linked=\"More on Mitcham Industries (NASDAQ:MIND): Q1 earnings miss across the board. Net profit fell 25%...\" data-tweet=\"$MIND - More on Mitcham Industries (NASDAQ:MIND): Q1 earnings miss across the board. Net profit fell 25% Y/Y as the seismic-equipment supplier posted weaker revenue, although margins improved to 53.5% from 48.8% on a 28% decline in input costs. Equipmen... https://seekingalpha.com/news/1064241?source=tweet\" data-url=\"https://seekingalpha.com/news/1064241\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064201\" data-ts=\"1370377687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064201\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ambarella (NASDAQ:AMBA): Q1 EPS of $0.21 beats by $0.08. Revenue of $33.9M (+30.9% Y/Y) beats by...</a></h4><b>Ambarella (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMBA\" title=\"Ambarella\">AMBA</a>):</b> Q1 EPS of $0.21 <font color=\"green\">beats by $0.08</font>. Revenue of $33.9M (+30.9% Y/Y) <font color=\"green\">beats by $2M</font>. (PR)<div class=\"tiny-share-widget\" data-id=\"1064201\" data-linked=\"Ambarella (NASDAQ:AMBA): Q1 EPS of $0.21 beats by $0.08. Revenue of $33.9M (+30.9% Y/Y) beats by...\" data-tweet=\"$AMBA - Ambarella (NASDAQ:AMBA): Q1 EPS of $0.21 beats by $0.08. Revenue of $33.9M (+30.9% Y/Y) beats by $2M. (PR) https://seekingalpha.com/news/1064201?source=tweet\" data-url=\"https://seekingalpha.com/news/1064201\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064111\" data-ts=\"1370376865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BV-OLD\" target=\"_blank\">BV-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064111\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bazaarvoice (NASDAQ:BV-OLD): FQ4 EPS of -$0.12 beats by $0.01. Revenue of $43.3M beats by...</a></h4><b>Bazaarvoice (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BV-OLD\" title=\"Bazaarvoice\">BV-OLD</a>):</b> FQ4 EPS of -$0.12 <font color=\"green\">beats by $0.01</font>. Revenue of $43.3M <font color=\"green\">beats by $0.81M</font>. Shares  <font color=\"green\">+5.9%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1064111\" data-linked=\"Bazaarvoice (NASDAQ:BV-OLD): FQ4 EPS of -$0.12 beats by $0.01. Revenue of $43.3M beats by...\" data-tweet=\"$BV-OLD - Bazaarvoice (NASDAQ:BV-OLD): FQ4 EPS of -$0.12 beats by $0.01. Revenue of $43.3M beats by $0.81M. Shares +5.9% AH. (PR) https://seekingalpha.com/news/1064111?source=tweet\" data-url=\"https://seekingalpha.com/news/1064111\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064101\" data-ts=\"1370376742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/END\" target=\"_blank\">END</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading note: Endeavour (END +8%) spiked on high volume during the final hour of trading,...</a></h4>Trading note: Endeavour (<a href='https://seekingalpha.com/symbol/END' title='Endeavour International Corporation'>END</a> <font color=\"green\">+8%</font>) <a href=\"http://www.streetinsider.com/Trader+Talk/Endeavour+%28END%29+Spikes+Late+on+Tuesday/8390271.html\" target=\"_blank\">spiked </a> on high volume during the final hour of trading, closing near its high with no specific news driver.<div class=\"tiny-share-widget\" data-id=\"1064101\" data-linked=\"Trading note: Endeavour (END +8%) spiked on high volume during the final hour of trading,...\" data-tweet=\"$END - Trading note: Endeavour (END +8%) spiked on high volume during the final hour of trading, closing near its high with no specific news driver. https://seekingalpha.com/news/1064101?source=tweet\" data-url=\"https://seekingalpha.com/news/1064101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064091\" data-ts=\"1370376731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHFL\" target=\"_blank\">SHFL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064091\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shuffle Master (NASDAQ:SHFL): FQ2 EPS of $0.21 beats by $0.01. Revenue of $77.4M beats by...</a></h4><b>Shuffle Master (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SHFL\" title=\"SHFL entertainment, Inc.\">SHFL</a>):</b> FQ2 EPS of $0.21 <font color=\"green\">beats by $0.01</font>. Revenue of $77.4M <font color=\"green\">beats by $5.83M</font>. Shares  <font color=\"green\">+5.5%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1064091\" data-linked=\"Shuffle Master (NASDAQ:SHFL): FQ2 EPS of $0.21 beats by $0.01. Revenue of $77.4M beats by...\" data-tweet=\"$SHFL - Shuffle Master (NASDAQ:SHFL): FQ2 EPS of $0.21 beats by $0.01. Revenue of $77.4M beats by $5.83M. Shares +5.5% AH. (PR) https://seekingalpha.com/news/1064091?source=tweet\" data-url=\"https://seekingalpha.com/news/1064091\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064031\" data-ts=\"1370375672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064031\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint&#39;s (S +1%) board is thinking of delaying the company&#39;s June 12 shareholder vote on the...</a></h4><p>Sprint's (<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a> <font color=\"green\">+1%</font>) board is <a href=\"http://www.bloomberg.com/news/2013-06-04/sprint-said-to-consider-delaying-softbank-vote-to-give-dish-time.html\" target=\"_blank\">thinking of delaying</a> the company's June 12 shareholder vote on the SoftBank (<a href=\"https://seekingalpha.com/symbol/SFTBF\" title=\"SoftBank Group\">OTCPK:SFTBF</a>) deal to give Dish (<a href=\"https://seekingalpha.com/symbol/DISH\" title=\"DISH Network Corporation\">DISH</a> <font color=\"green\">+0.3%</font>) more time to strengthen its rival offer, Bloomberg reports. Though Sprint has appeared <a href=\"https://seekingalpha.com/currents/post/1006841\" target=\"_blank\">cool to Dish's overtures</a>, a Dish spokesman states his company is still negotiating with Sprint. One source claims Dish, which recently raised $2.6B in debt, has lined up $9.3B in financing for its Sprint bid. Clearwire (<a href=\"https://seekingalpha.com/symbol/CLWR\" title=\"\">CLWR</a> <font color=\"red\">-2.6%</font>) has sold off to $4.31 today, below Dish's $4.40/share offer price, as investors weigh Sprint's <a href=\"https://seekingalpha.com/currents/post/1061181\" target=\"_blank\">legal assertions</a>. (<a href=\"https://seekingalpha.com/currents/search?query=sprint%20dish\" target=\"_blank\">previous</a>)</p><div class=\"tiny-share-widget\" data-id=\"1064031\" data-linked=\"Sprint&#39;s (S +1%) board is thinking of delaying the company&#39;s June 12 shareholder vote on the...\" data-tweet=\"$S $S $SFTBF - Sprint&#39;s (S +1%) board is thinking of delaying the company&#39;s June 12 shareholder vote on the SoftBank (OTCPK:SFTBF) deal to give Dish (DISH +0.3%) more time to strengthen its rival offer, Bloomberg reports. Though Sprint has appeared cool... https://seekingalpha.com/news/1064031?source=tweet\" data-url=\"https://seekingalpha.com/news/1064031\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064021\" data-ts=\"1370375267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOL\" target=\"_blank\">TOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064021\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Toll Brothers (TOL -1.2%) slips today, despite being upgraded to a Buy by analyst Megan McGrath...</a></h4>Toll Brothers (<a href='https://seekingalpha.com/symbol/TOL' title='Toll Brothers Inc.'>TOL</a> <font color=\"red\">-1.2%</font>) slips today, despite being <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/06/3647124/update-toll-shares-lower-despite-upgrade-from-mkm-partne\" target=\"_blank\">upgraded to a Buy</a> by analyst Megan McGrath at MKM Partners. McGrath says that <a href='https://seekingalpha.com/symbol/TOL' title='Toll Brothers Inc.'>TOL</a>'s status as one of the more niche luxury homebuilders may become more valuable as the housing market continues to grow and lower end competition intensifies. She recommends investors buy the shares ahead of H213 as the stock could be pushed higher by the closing of the Touraine building.<div class=\"tiny-share-widget\" data-id=\"1064021\" data-linked=\"Toll Brothers (TOL -1.2%) slips today, despite being upgraded to a Buy by analyst Megan McGrath...\" data-tweet=\"$TOL - Toll Brothers (TOL -1.2%) slips today, despite being upgraded to a Buy by analyst Megan McGrath at MKM Partners. McGrath says that TOL&#39;s status as one of the more niche luxury homebuilders may become more valuable as the housing market continues ... https://seekingalpha.com/news/1064021?source=tweet\" data-url=\"https://seekingalpha.com/news/1064021\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1064011\" data-ts=\"1370374488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAGDF\" target=\"_blank\">CAGDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1064011\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Centerra Gold (OTCPK:CAGDF +5.8%) says it is in talks with the government of Kyrgyzstan about...</a></h4><p>Centerra Gold (<a href=\"https://seekingalpha.com/symbol/CAGDF\" title=\"Centerra Gold Inc.\">OTCPK:CAGDF</a> <font color=\"green\">+5.8%</font>) says it is in talks with the government of Kyrgyzstan about <a href=\"http://online.wsj.com/article/SB10001424127887324063304578525524091809876.html\" target=\"_blank\">taking a direct stake</a> in the Kumtor mine, which was shut down temporarily <a href=\"https://seekingalpha.com/currents/post/1057171\" target=\"_blank\">last week</a> by protesters. A proposed deal would have the government exchange its 32.7% equity stake in Centerra for a stake of equivalent value in a joint-venture company that would own the Kumtor mine.</p><div class=\"tiny-share-widget\" data-id=\"1064011\" data-linked=\"Centerra Gold (OTCPK:CAGDF +5.8%) says it is in talks with the government of Kyrgyzstan about...\" data-tweet=\"$CAGDF - Centerra Gold (OTCPK:CAGDF +5.8%) says it is in talks with the government of Kyrgyzstan about taking a direct stake in the Kumtor mine, which was shut down temporarily last week by protesters. A proposed deal would have the government exchange ... https://seekingalpha.com/news/1064011?source=tweet\" data-url=\"https://seekingalpha.com/news/1064011\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063951\" data-ts=\"1370373517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMY\" target=\"_blank\">HMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063951\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A blip during a turnaround, or a new leg downward for gold miners (GDX -2.4%)? After stringing...</a></h4><p>A blip during a <a href=\"https://seekingalpha.com/currents/post/1061201\" target=\"_blank\">turnaround</a>, or a new leg downward for gold miners (<a href=\"https://seekingalpha.com/symbol/GDX\" title=\"VanEck Vectors Gold Miners ETF\">GDX</a> <font color=\"red\">-2.4%</font>)? After stringing together several strong days, South African gold miners <a href=\"http://blogs.barrons.com/emergingmarketsdaily/2013/06/04/gold-tumbles-south-african-miners-fall/\" target=\"_blank\">take a beating</a> today as <a href=\"https://seekingalpha.com/currents/post/1063501\" target=\"_blank\">gold prices slide</a> after a two-week rally: <a href=\"https://seekingalpha.com/symbol/HMY\" title=\"Harmony Gold Mining Company Limited\">HMY</a> <font color=\"red\">-6.2%</font>, <a href=\"https://seekingalpha.com/symbol/SBGL\" title=\"Sibanye-Stillwater\">SBGL</a> <font color=\"red\">-4.2%</font>, <a href=\"https://seekingalpha.com/symbol/AU\" title=\"AngloGold Ashanti Limited\">AU</a> <font color=\"red\">-3.3%</font>, <a href=\"https://seekingalpha.com/symbol/GFI\" title=\"Gold Fields Limited\">GFI</a> <font color=\"red\">-2.2%</font>. News that Barrick Gold (ABX <font color=\"red\">-3.2%</font>) <a href=\"https://seekingalpha.com/currents/post/1062421\" target=\"_blank\">will delay production</a> at its Pascua-Lama mine may be adding to jitters over government risk.</p><div class=\"tiny-share-widget\" data-id=\"1063951\" data-linked=\"A blip during a turnaround, or a new leg downward for gold miners (GDX -2.4%)? After stringing...\" data-tweet=\"$HMY $GDX $HMY - A blip during a turnaround, or a new leg downward for gold miners (GDX -2.4%)? After stringing together several strong days, South African gold miners take a beating today as gold prices slide after a two-week rally: HMY -6.2%, SBGL -4.... https://seekingalpha.com/news/1063951?source=tweet\" data-url=\"https://seekingalpha.com/news/1063951\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063971\" data-ts=\"1370373409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDCO\" target=\"_blank\">MDCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063971\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Medicines Company (MDCO -1.4%) agrees to buy all of the outstanding capital stock of...</a></h4><p>The Medicines Company (<a href=\"https://seekingalpha.com/symbol/MDCO\" title=\"The Medicines Company\">MDCO</a> <font color=\"red\">-1.4%</font>) agrees to buy all of the outstanding capital stock of ProFibrix, subject to the company's satisfactory review of the pending Phase 3 clinical trial results of ProFibrix's lead biologic Fibrocaps. Under the terms of the agreement, <a href=\"https://seekingalpha.com/symbol/MDCO\" title=\"The Medicines Company\">MDCO</a> will pay ProFibrix a $10M upfront option payment. If the company is satisfied with the trial results of the trial and decides to proceed, it will purchase all of the outstanding capital stock of ProFibrix at closing.</p><div class=\"tiny-share-widget\" data-id=\"1063971\" data-linked=\"The Medicines Company (MDCO -1.4%) agrees to buy all of the outstanding capital stock of...\" data-tweet=\"$MDCO - The Medicines Company (MDCO -1.4%) agrees to buy all of the outstanding capital stock of ProFibrix, subject to the company&#39;s satisfactory review of the pending Phase 3 clinical trial results of ProFibrix&#39;s lead biologic Fibrocaps. Under the term... https://seekingalpha.com/news/1063971?source=tweet\" data-url=\"https://seekingalpha.com/news/1063971\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063891\" data-ts=\"1370372205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CP\" target=\"_blank\">CP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC Capital puts a little more heft into Canadian Pacific&#39;s (CP -3.4%) slide, after it...</a></h4><p>RBC Capital puts a little more heft into Canadian Pacific's (<a href=\"https://seekingalpha.com/symbol/CP\" title=\"Canadian Pacific Railway Limited\">CP</a> <font color=\"red\">-3.4%</font>) slide, after it <a href=\"http://www.streetinsider.com/Downgrades/RBC+Capital+Downgrades+Canadian+Pacific+Railway+Limited+%28CP%29+to+Underperform/8387743.html\" target=\"_blank\">downgrades the shares</a> to Underperform today with a price target of $100.78. The stock was already feeling the weight of <a href=\"https://seekingalpha.com/market_currents/post/1061551\" target=\"_blank\">Pershing Square's disclosure</a> late yesterday that it intended to sell up to 7M shares, or roughly 30% of its outstanding stake.</p><div class=\"tiny-share-widget\" data-id=\"1063891\" data-linked=\"RBC Capital puts a little more heft into Canadian Pacific&#39;s (CP -3.4%) slide, after it...\" data-tweet=\"$CP - RBC Capital puts a little more heft into Canadian Pacific&#39;s (CP -3.4%) slide, after it downgrades the shares to Underperform today with a price target of $100.78. The stock was already feeling the weight of Pershing Square&#39;s disclosure late yester... https://seekingalpha.com/news/1063891?source=tweet\" data-url=\"https://seekingalpha.com/news/1063891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063881\" data-ts=\"1370371800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora (P -4.1%) bleeds for the second day in a row (previous) on concerns about iRadio&#39;s...</a></h4><p>Pandora (<a href=\"https://seekingalpha.com/symbol/P\" title=\"Pandora Media\">P</a> <font color=\"red\">-4.1%</font>) bleeds for the second day in a row (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1060111\">previous</a>) on concerns about iRadio's impact. CFO Mike Herring's efforts at a BofA/Merrill conference to <a target=\"_blank\" href=\"http://www.marketwatch.com/story/pandora-cfo-plays-down-possible-apple-competition-2013-06-04\">downplay the threat</a> aren't doing much to help. A Bloomberg report claiming Apple is <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2013-06-03/apple-said-to-shift-ad-focus-to-support-new-music-service.html\">ramping its iRadio ad sales efforts</a> and will share ad revenue with studios (apparently in return for <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/562251\">playback options</a> not supported by rivals) could be adding to the pressure. Will Apple disrupt Pandora in a way that Spotify, Amazon, Google, Sony, Microsoft, TuneIn, and Songza have thus far failed to?</p><div class=\"tiny-share-widget\" data-id=\"1063881\" data-linked=\"Pandora (P -4.1%) bleeds for the second day in a row (previous) on concerns about iRadio&#39;s...\" data-tweet=\"$P - Pandora (P -4.1%) bleeds for the second day in a row (previous) on concerns about iRadio&#39;s impact. CFO Mike Herring&#39;s efforts at a BofA/Merrill conference to downplay the threat aren&#39;t doing much to help. A Bloomberg report claiming Apple is rampin... https://seekingalpha.com/news/1063881?source=tweet\" data-url=\"https://seekingalpha.com/news/1063881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063861\" data-ts=\"1370371426\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOBS\" target=\"_blank\">BOBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063861\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Brazil Fast Food (OTCPK:BOBS +7.7%) rise sharply in characteristically thin trading...</a></h4><p>Shares of Brazil Fast Food (<a href=\"https://seekingalpha.com/symbol/BOBS\" title=\"Brazil Fast Food Corp.\">OTCPK:BOBS</a> <font color=\"green\">+7.7%</font>) rise sharply in characteristically thin trading after SA Pro contributor Nick Ghattas says the company \"is <a href=\"https://seekingalpha.com/article/1479631-brazil-fast-food-has-a-margin-of-safety-with-significant-upside\" target=\"_blank\">about to become a cash cow</a> [and has] significant competitive advantages\" in an article published today (still under embargo).</p><div class=\"tiny-share-widget\" data-id=\"1063861\" data-linked=\"Shares of Brazil Fast Food (OTCPK:BOBS +7.7%) rise sharply in characteristically thin trading...\" data-tweet=\"$BOBS - Shares of Brazil Fast Food (OTCPK:BOBS +7.7%) rise sharply in characteristically thin trading after SA Pro contributor Nick Ghattas says the company &quot;is about to become a cash cow [and has] significant competitive advantages&quot; in an article publi... https://seekingalpha.com/news/1063861?source=tweet\" data-url=\"https://seekingalpha.com/news/1063861\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063851\" data-ts=\"1370371218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDGL\" target=\"_blank\">MDGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063851\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synta Pharmaceuticals (SNTA +2.7%) moves up today, after the company announced earlier that it...</a></h4><p>Synta Pharmaceuticals (SNTA <font color=\"green\">+2.7%</font>) moves up today, after the company announced earlier that it will be presenting at the Jefferies 2013 Global Healthcare Conference on Thursday, June 6, in New York.</p><div class=\"tiny-share-widget\" data-id=\"1063851\" data-linked=\"Synta Pharmaceuticals (SNTA +2.7%) moves up today, after the company announced earlier that it...\" data-tweet=\"$MDGL - Synta Pharmaceuticals (SNTA +2.7%) moves up today, after the company announced earlier that it will be presenting at the Jefferies 2013 Global Healthcare Conference on Thursday, June 6, in New York. https://seekingalpha.com/news/1063851?source=tweet\" data-url=\"https://seekingalpha.com/news/1063851\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063821\" data-ts=\"1370370535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Copper rallies (JJC +1%) on expectations of tighter supplies, as the potential rises for an...</a></h4><a href=\"http://www.ft.com/intl/cms/s/0/4cf1b09c-cd2c-11e2-90e8-00144feab7de.html#axzz2VFzJ0qQQ\" target=\"_blank\">Copper rallies</a> (<a href='https://seekingalpha.com/symbol/JJC' title='iPath Series B Bloomberg Copper Subindex Total Return ETN'>JJC</a> <font color=\"green\">+1%</font>) on expectations of tighter supplies, as the <a href=\"https://seekingalpha.com/currents/post/1059831\" target=\"_blank\">potential rises for an extended shutdown</a> at Freeport McMoRan's (<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color=\"red\">-2.5%</font>) Grasberg copper and gold mining operation in Indonesia. If FCX were to declare force majeure, the shutdown could remove 100K-150K metric tons of copper supply from the market, a sizable chunk out of estimates of 600K-800K metric tons.<div class=\"tiny-share-widget\" data-id=\"1063821\" data-linked=\"Copper rallies (JJC +1%) on expectations of tighter supplies, as the potential rises for an...\" data-tweet=\"$FCX $JJCTF $FCX - Copper rallies (JJC +1%) on expectations of tighter supplies, as the potential rises for an extended shutdown at Freeport McMoRan&#39;s (FCX -2.5%) Grasberg copper and gold mining operation in Indonesia. If FCX were to declare force majeu... https://seekingalpha.com/news/1063821?source=tweet\" data-url=\"https://seekingalpha.com/news/1063821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063741\" data-ts=\"1370369134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELN\" target=\"_blank\">ELN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063741\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Institutional Shareholder Services is recommending Elan (ELN +0.6%) shareholders vote against...</a></h4><p>Institutional Shareholder Services is recommending Elan (<a href=\"https://seekingalpha.com/symbol/ELN\" title=\"Elan Corporation, plc\">ELN</a> <font color=\"green\">+0.6%</font>) <a href=\"http://www.cnbc.com/id/100786159\" target=\"_blank\">shareholders vote</a> against several company proposals - including a $1B royalty-sharing agreement with Theravance (THRX <font color=\"red\">-1.5%</font>) and a $200M stock buyback program at <a href=\"https://seekingalpha.com/symbol/ELN\" title=\"Elan Corporation, plc\">ELN</a>'s June 17 special meeting. It withholds recommendation on the Royalty all-cash offer however, although it said voting against <a href=\"https://seekingalpha.com/symbol/ELN\" title=\"Elan Corporation, plc\">ELN</a>'s proposals \"leaves the door open for shareholders to tender their shares if they so wish.\"</p><div class=\"tiny-share-widget\" data-id=\"1063741\" data-linked=\"Institutional Shareholder Services is recommending Elan (ELN +0.6%) shareholders vote against...\" data-tweet=\"$ELN $ELN $INVA - Institutional Shareholder Services is recommending Elan (ELN +0.6%) shareholders vote against several company proposals - including a $1B royalty-sharing agreement with Theravance (THRX -1.5%) and a $200M stock buyback program at ELN&#39;s... https://seekingalpha.com/news/1063741?source=tweet\" data-url=\"https://seekingalpha.com/news/1063741\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063711\" data-ts=\"1370368442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RBCN\" target=\"_blank\">RBCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063711\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rubicon (RBCN +2.8%) jumps in response to an SA Pro article (still under embargo) from...</a></h4><p>Rubicon (<a href=\"https://seekingalpha.com/symbol/RBCN\" title=\"Rubicon Technology, Inc.\">RBCN</a> <font color=\"green\">+2.8%</font>) jumps in response to an SA Pro article (still under embargo) from contributor <a target=\"_blank\" href=\"https://seekingalpha.com/article/1477041-buy-rubicon-ahead-of-cyclical-and-secular-upturn\">Valuable Insights</a>. The author argues the beaten-down and heavily-shorted LED wafer vendor is due to see an upcycle, thanks to <a target=\"_blank\" href=\"http://bit.ly/1aPAoby\">strong LED lighting demand</a> and an improving pricing environment (the current environment, in which 2\" and 4\" wafers are being <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1006671\">sold below cost</a>, is deemed \"unsustainable\"). Comparisons are made with Micron and First Solar, both of which have <a target=\"_blank\" href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1369944000000&amp;chddm=54727&amp;chls=IntervalBasedLine&amp;cmpto=NASDAQ:FSLR&amp;cmptdms=0&amp;q=NASDAQ:MU&amp;ntsp=0&amp;ei=VSmuUbDVCKO1iAK-VQ\">taken off</a> since last fall with the help of improving cyclical conditions in their respective industries.</p><div class=\"tiny-share-widget\" data-id=\"1063711\" data-linked=\"Rubicon (RBCN +2.8%) jumps in response to an SA Pro article (still under embargo) from...\" data-tweet=\"$RBCN - Rubicon (RBCN +2.8%) jumps in response to an SA Pro article (still under embargo) from contributor Valuable Insights. The author argues the beaten-down and heavily-shorted LED wafer vendor is due to see an upcycle, thanks to strong LED lighting ... https://seekingalpha.com/news/1063711?source=tweet\" data-url=\"https://seekingalpha.com/news/1063711\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063701\" data-ts=\"1370368215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HALO\" target=\"_blank\">HALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063701\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The day chart for Halozyme Therapeutics (HALO -5.9%) looks almost identical to yesterday&#39;s...</a></h4><p>The day chart for Halozyme Therapeutics (<a href=\"https://seekingalpha.com/symbol/HALO\" title=\"Halozyme Therapeutics, Inc.\">HALO</a> <font color=\"red\">-5.9%</font>) looks almost identical to yesterday's \u2014 and that is not a good thing. After briefly trading in positive territory, shares have fallen steadily throughout the session putting the two-day loss at <font color=\"red\">~8.4%</font> as investors continue to unload their shares after the company presented data from a Phase 1b trial testing a PEGPH20/ gemcitabine combo in pancreatic cancer patients. (<a href=\"https://seekingalpha.com/currents/post/1060461\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/1032601\" target=\"_blank\">II</a>)</p><div class=\"tiny-share-widget\" data-id=\"1063701\" data-linked=\"The day chart for Halozyme Therapeutics (HALO -5.9%) looks almost identical to yesterday&#39;s \u2014 and...\" data-tweet=\"$HALO - The day chart for Halozyme Therapeutics (HALO -5.9%) looks almost identical to yesterday&#39;s \u2014 and that is not a good thing. After briefly trading in positive territory, shares have fallen steadily throughout the session putting the two-day loss a... https://seekingalpha.com/news/1063701?source=tweet\" data-url=\"https://seekingalpha.com/news/1063701\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063661\" data-ts=\"1370367803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAIN\" target=\"_blank\">MAIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063661\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Main Street Capital (MAIN -4.2%) continues for a 2nd day to bear the brunt of the selling in the...</a></h4><p>Main Street Capital (<a href=\"https://seekingalpha.com/symbol/MAIN\" title=\"Main Street Capital\">MAIN</a> <font color=\"red\">-4.2%</font>) continues for a 2nd day to bear the brunt of the selling in the BDC sector (<a href=\"https://seekingalpha.com/symbol/BDCS\" title=\"UBS ETRACS Wells Fargo Business Development Company ETN\">BDCS</a> <font color=\"red\">-0.7%</font>). The company's just-published<a href=\"http://files.shareholder.com/downloads/MAIN/2441260575x0x668578/B6150776-3176-4B26-8DF8-08F169D4C088/Main_Street_Analyst_Investor_Day_June_2013.pdf\" target=\"_blank\"> investor day presentation</a> is typical conference stuff - showing how the company is different (and superior) to its sector brethren, explaining the opportunities in lower and middle-market lending, and including several case studies. Also notably lower: MCG Capital (<a href=\"https://seekingalpha.com/symbol/MCGC\" title=\"MCG Capital\">MCGC</a> <font color=\"red\">-1.6%</font>), Prospect (<a href=\"https://seekingalpha.com/symbol/PSEC\" title=\"Prospect Capital Corporation\">PSEC</a> <font color=\"red\">-1.3%</font>), and Hercules (<a href=\"https://seekingalpha.com/symbol/HTGC\" title=\"Hercules Capital, Inc.\">HTGC</a> <font color=\"red\">-1%</font>).</p><div class=\"tiny-share-widget\" data-id=\"1063661\" data-linked=\"Main Street Capital (MAIN -4.2%) continues for a 2nd day to bear the brunt of the selling in the...\" data-tweet=\"$MAIN $MAIN $BDCS - Main Street Capital (MAIN -4.2%) continues for a 2nd day to bear the brunt of the selling in the BDC sector (BDCS -0.7%). The company&#39;s just-published investor day presentation is typical conference stuff - showing how the company is... https://seekingalpha.com/news/1063661?source=tweet\" data-url=\"https://seekingalpha.com/news/1063661\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063651\" data-ts=\"1370367339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWPH\" target=\"_blank\">GWPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063651\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GW Pharma (GWPH +1%) moves up after Canaccord initiated coverage earlier today with a Buy rating...</a></h4><p>GW Pharma (<a href=\"https://seekingalpha.com/symbol/GWPH\" title=\"GW Pharmaceuticals plc\">GWPH</a> <font color=\"green\">+1%</font>) moves up after Canaccord <a href=\"http://www.streetinsider.com/New+Coverage/Canaccord+Genuity+Starts+GW+Pharma+%28GWPH%29+at+Buy/8387873.html\" target=\"_blank\">initiated coverage</a> earlier today with a Buy rating and a $13 price target.</p><div class=\"tiny-share-widget\" data-id=\"1063651\" data-linked=\"GW Pharma (GWPH +1%) moves up after Canaccord initiated coverage earlier today with a Buy rating...\" data-tweet=\"$GWPH - GW Pharma (GWPH +1%) moves up after Canaccord initiated coverage earlier today with a Buy rating and a $13 price target. https://seekingalpha.com/news/1063651?source=tweet\" data-url=\"https://seekingalpha.com/news/1063651\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063591\" data-ts=\"1370366338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HYGS\" target=\"_blank\">HYGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063591\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hydrogenics (HYGS +7.2%) continues its relentless ascent. For those keeping score, the shares...</a></h4><p>Hydrogenics (<a href=\"https://seekingalpha.com/symbol/HYGS\" title=\"Hydrogenics Corporation\">HYGS</a> <font color=\"green\">+7.2%</font>) continues its relentless ascent. For those keeping score, the shares are now up <font color=\"green\"><b>~84%</b></font> since SA Pro contributor Joe Springer said the stock \"<a target=\"_blank\" href=\"https://seekingalpha.com/article/1456761-5-reasons-hydrogenics-could-triple\">could triple</a>\" on May 23. (Previous: <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1043951\">I</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1046541\">II</a>)</p><div class=\"tiny-share-widget\" data-id=\"1063591\" data-linked=\"Hydrogenics (HYGS +7.2%) continues its relentless ascent. For those keeping score, the shares...\" data-tweet=\"$HYGS - Hydrogenics (HYGS +7.2%) continues its relentless ascent. For those keeping score, the shares are now up ~84% since SA Pro contributor Joe Springer said the stock &quot;could triple&quot; on May 23. (Previous: I, II) https://seekingalpha.com/news/1063591?source=tweet\" data-url=\"https://seekingalpha.com/news/1063591\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063461\" data-ts=\"1370364640\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASM\" target=\"_blank\">CASM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063461\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CAS Medical Systems (CASM +4.6%) moves up after landing FDA 510(k) clearance for its...</a></h4><p>CAS Medical Systems (<a href=\"https://seekingalpha.com/symbol/CASM\" title=\"CAS Medical Systems, Inc.\">CASM</a> <font color=\"green\">+4.6%</font>) moves up after landing FDA 510(k) clearance for its next-generation 740 SelectTM vital signs monitor and its MAX IQ non-invasive blood pressure technology. The company plans to begin filling orders during Q313.</p><div class=\"tiny-share-widget\" data-id=\"1063461\" data-linked=\"CAS Medical Systems (CASM +4.6%) moves up after landing FDA 510(k) clearance for its...\" data-tweet=\"$CASM - CAS Medical Systems (CASM +4.6%) moves up after landing FDA 510(k) clearance for its next-generation 740 SelectTM vital signs monitor and its MAX IQ non-invasive blood pressure technology. The company plans to begin filling orders during Q313. https://seekingalpha.com/news/1063461?source=tweet\" data-url=\"https://seekingalpha.com/news/1063461\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063451\" data-ts=\"1370364362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTCT\" target=\"_blank\">CTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063451\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">E-mail/social media marketing software firm Constant Contact (CTCT +4.5%) and cloud contact...</a></h4>E-mail/social media marketing software firm Constant Contact (<a href='https://seekingalpha.com/symbol/CTCT' title='Constant Contact, Inc.'>CTCT</a> <font color=\"green\">+4.5%</font>) and cloud contact center software firm inContact (<a href='https://seekingalpha.com/symbol/SAAS' title='inContact, Inc.'>SAAS</a> <font color=\"green\">+7.4%</font>) join the list of names rallying on <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1062691\">hopes</a> the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1062211\">Salesforce-ExactTarget deal</a> will spur further M&amp;A activity. <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/Salesforce+%28CRM%29+ExactTarget+%28ET%29+Deal+Signals+Shift+in+Strategy/8389344.html\">Wells Fargo </a>observes Salesforce (<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a> <font color=\"red\">-3.1%</font>) stated the bidding for ExactTarget (NYSE:<a href='https://seekingalpha.com/symbol/ET-OLD' title='Energy Transfer LP'>ET-OLD</a>) was competitive, which leads it to think SAP or IBM may be interested. Though wondering if Salesforce will be able to tie together its acquisitions, <a target=\"_blank\" href=\"http://gigaom.com/2013/06/04/salesforce-is-buying-exact-target-for-2-5-billion/\">Om Malik</a> thinks the deal makes sense on paper, given ExactTarget's e-mail-focused offerings add \"more structure to Salesforce&rsquo;s ambiguous sounding Marketing Cloud.\" <a target=\"_blank\" href=\"http://news.yahoo.com/salesforce-buy-marketing-software-maker-exacttarget-2-5-114530726.html\">Marc Benioff </a>suggests Salesforce is now likely to \"[take] a vacation\" from M&amp;A for 12-18 months.<div class=\"tiny-share-widget\" data-id=\"1063451\" data-linked=\"E-mail/social media marketing software firm Constant Contact (CTCT +4.5%) and cloud contact...\" data-tweet=\"$CTCT $CTCT $SAAS - E-mail/social media marketing software firm Constant Contact (CTCT +4.5%) and cloud contact center software firm inContact (SAAS +7.4%) join the list of names rallying on hopes the Salesforce-ExactTarget deal will spur further M&amp;A ac... https://seekingalpha.com/news/1063451?source=tweet\" data-url=\"https://seekingalpha.com/news/1063451\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063391\" data-ts=\"1370362815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNXL\" target=\"_blank\">UNXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063391\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UniPixel (UNXL +6.7%) rallies after announcing it&#39;s showing off 10.1&quot; and 13.3&quot; UniBoss touch...</a></h4><p>UniPixel (<a href=\"https://seekingalpha.com/symbol/UNXL\" title=\"Uni-Pixel, Inc.\">UNXL</a> <font color=\"green\">+6.7%</font>) rallies after announcing it's showing off 10.1\" and 13.3\" <a href=\"http://www.unipixel.com/uniboss-touch-sensor-images\" target=\"_blank\">UniBoss</a> touch sensor prototypes at this week's Computex trade show. The company says the prototypes are the same ones it recently showed off at Cowen and Craig-Hallum conferences, and don't \"show any extraneous effects when viewing the display.\" Shares remain well below where they traded before SA contributor Seth Shaw <a href=\"https://seekingalpha.com/currents/post/1057971\" target=\"_blank\">posted pictures</a> of UniBoss demo units with visible lines in a Friday column.</p><div class=\"tiny-share-widget\" data-id=\"1063391\" data-linked=\"UniPixel (UNXL +6.7%) rallies after announcing it&#39;s showing off 10.1&quot; and 13.3&quot; UniBoss touch...\" data-tweet=\"$UNXL - UniPixel (UNXL +6.7%) rallies after announcing it&#39;s showing off 10.1&quot; and 13.3&quot; UniBoss touch sensor prototypes at this week&#39;s Computex trade show. The company says the prototypes are the same ones it recently showed off at Cowen and Craig-Hallu... https://seekingalpha.com/news/1063391?source=tweet\" data-url=\"https://seekingalpha.com/news/1063391\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063361\" data-ts=\"1370361932\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXN\" target=\"_blank\">TXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chip stocks outperform (SOXX +1.4%) after Microchip raises its June quarter guidance, and...</a></h4><p>Chip stocks outperform (<a href=\"https://seekingalpha.com/symbol/SOXX\" title=\"iShares PHLX SOX Semiconductor Sector Index ETF\">SOXX</a> <font color=\"green\">+1.4%</font>) after <a href=\"https://seekingalpha.com/currents/post/1061611\" target=\"_blank\">Microchip</a> raises its June quarter guidance, and <a href=\"https://seekingalpha.com/currents/post/1061961\" target=\"_blank\">STMicroelectronics</a> raises its 2013 guidance. Microchip rivals Texas Instruments (<a href=\"https://seekingalpha.com/symbol/TXN\" title=\"Texas Instruments Inc.\">TXN</a> <font color=\"green\">+2.6%</font>), Atmel (<a href=\"https://seekingalpha.com/symbol/ATML\" title=\"Atmel Corporation\">ATML</a> <font color=\"green\">+3.4%</font>), and Freescale (<a href=\"https://seekingalpha.com/symbol/FSL\" title=\"Freescale Semiconductor Inc.\">FSL</a> <font color=\"green\">+2.1%</font>) are among the winners, as is STMicroelectronics rival NXP (<a href=\"https://seekingalpha.com/symbol/NXPI\" title=\"NXP Semiconductors\">NXPI</a> <font color=\"green\">+3.6%</font>). Also, Altera (<a href=\"https://seekingalpha.com/symbol/ALTR\" title=\"Altair Engineering, Inc.  Cl A\">ALTR</a> <font color=\"green\">+2.5%</font>) is rallying with the help of an upgrade to Buy from Argus, and Intersil (<a href=\"https://seekingalpha.com/symbol/ISIL\" title=\"Intersil Corporation\">ISIL</a> <font color=\"green\">+2.4%</font>) is benefiting from a bullish coverage launch from Piper. Some chip ETFs: <a href=\"https://seekingalpha.com/symbol/SMH\" title=\"VanEck Vectors Semiconductor ETF\">SMH</a>, <a href=\"https://seekingalpha.com/symbol/XSD\" title=\"SPDR S&amp;P Semiconductor ETF\">XSD</a>, <a href=\"https://seekingalpha.com/symbol/PSI\" title=\"Invesco Dynamic Semiconductors Portfolio ETF\">PSI</a>, <a href=\"https://seekingalpha.com/symbol/SOXL\" title=\"Direxion Daily Semiconductor 3x Bull Shares ETF\">SOXL</a>, <a href=\"https://seekingalpha.com/symbol/USD\" title=\"ProShares Ultra Semiconductors ETF\">USD</a>, <a href=\"https://seekingalpha.com/symbol/SOXS\" title=\"Direxion Daily Semiconductor 3x Bear Shares ETF\">SOXS</a>, <a href=\"https://seekingalpha.com/symbol/SSG\" title=\"ProShares UltraShort Semiconductors ETF\">SSG</a>.</p><div class=\"tiny-share-widget\" data-id=\"1063361\" data-linked=\"Chip stocks outperform (SOXX +1.4%) after Microchip raises its June quarter guidance, and...\" data-tweet=\"$TXN $SOXX $TXN - Chip stocks outperform (SOXX +1.4%) after Microchip raises its June quarter guidance, and STMicroelectronics raises its 2013 guidance. Microchip rivals Texas Instruments (TXN +2.6%), Atmel (ATML +3.4%), and Freescale (FSL +2.1%) are am... https://seekingalpha.com/news/1063361?source=tweet\" data-url=\"https://seekingalpha.com/news/1063361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063281\" data-ts=\"1370361253\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBTH\" target=\"_blank\">PBTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063281\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prolor Biotech (PBTH -2%) says it&#39;s initiated Phase III clinical trials of hGH-CTP, a human...</a></h4><p>Prolor Biotech (<a href=\"https://seekingalpha.com/symbol/PBTH\" title=\"PROLOR Biotech Inc\">PBTH</a> <font color=\"red\">-2%</font>) says it's initiated Phase III clinical trials of hGH-CTP, a human growth hormone that provides deficient adults and children with hGH therapy that may require only once-weekly or bi-monthly injections, rather than the daily injections required by current hGH therapy.</p><div class=\"tiny-share-widget\" data-id=\"1063281\" data-linked=\"Prolor Biotech (PBTH -2%) says it&#39;s initiated Phase III clinical trials of hGH-CTP, a human...\" data-tweet=\"$PBTH - Prolor Biotech (PBTH -2%) says it&#39;s initiated Phase III clinical trials of hGH-CTP, a human growth hormone that provides deficient adults and children with hGH therapy that may require only once-weekly or bi-monthly injections, rather than the d... https://seekingalpha.com/news/1063281?source=tweet\" data-url=\"https://seekingalpha.com/news/1063281\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063251\" data-ts=\"1370360589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QEP\" target=\"_blank\">QEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063251\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">QEP&amp;nbsp;Resources (QEP +3.5%) is one of the biggest gainers in the S&amp;amp;P 500 after the oil...</a></h4><p>QEPResources (<a href=\"https://seekingalpha.com/symbol/QEP\" title=\"QEP Resources, Inc.\">QEP</a> <font color=\"green\">+3.5%</font>) is one of the biggest gainers in the S&amp;P 500 after the oil and gas E&amp;P company provided an operations update yesterday. QEP says it has completed and turned to sales its first four-well pad on the South Antelope property in North Dakota's Williston Basin, and completed nine new wells at the Fort Berthold Indian Reservation.</p><div class=\"tiny-share-widget\" data-id=\"1063251\" data-linked=\"QEPResources (QEP +3.5%) is one of the biggest gainers in the S&amp;amp;P 500 after the oil and gas...\" data-tweet=\"$QEP - QEPResources (QEP +3.5%) is one of the biggest gainers in the S&amp;P 500 after the oil and gas E&amp;P company provided an operations update yesterday. QEP says it has completed and turned to sales its first four-well pad on the South Antelope property... https://seekingalpha.com/news/1063251?source=tweet\" data-url=\"https://seekingalpha.com/news/1063251\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063241\" data-ts=\"1370359994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MACK\" target=\"_blank\">MACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063241\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merrimack Pharmaceuticals (MACK -4.3%) says that results from a Phase 1 clinical study show that...</a></h4><p>Merrimack Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/MACK\" title=\"Merrimack Pharmaceuticals\">MACK</a> <font color=\"red\">-4.3%</font>) says that results from a Phase 1 clinical study show that its antibody MM-121 could be combined with standard doses of certain cytotoxic agents for investigation as treatment for patients with advanced solid tumors. MM-121 is a fully human monoclonal antibody that targets ErbB3, a cell surface receptor implicated in tumor growth.</p><div class=\"tiny-share-widget\" data-id=\"1063241\" data-linked=\"Merrimack Pharmaceuticals (MACK -4.3%) says that results from a Phase 1 clinical study show that...\" data-tweet=\"$MACK - Merrimack Pharmaceuticals (MACK -4.3%) says that results from a Phase 1 clinical study show that its antibody MM-121 could be combined with standard doses of certain cytotoxic agents for investigation as treatment for patients with advanced soli... https://seekingalpha.com/news/1063241?source=tweet\" data-url=\"https://seekingalpha.com/news/1063241\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063231\" data-ts=\"1370359814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVN\" target=\"_blank\">INVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063231\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InvenSense (INVN +5.6%) jumps after Maxim reports the company has scored a motion sensor design...</a></h4><p>InvenSense (<a href=\"https://seekingalpha.com/symbol/INVN\" title=\"InvenSense\">INVN</a> <font color=\"green\">+5.6%</font>) jumps after Maxim reports the company has scored a motion sensor design win for the next version of Google's Nexus 7 - the current model <a href=\"http://www.isuppli.com/Teardowns/News/pages/Low-End-Google-Nexus-7-Carries-%24157-BOM-Teardown-Reveals.aspx\" target=\"_blank\">also uses</a> an InvenSense sensor chip. The next-gen 7 is <a href=\"http://www.ubergizmo.com/2013/05/googles-next-gen-nexus-7-rumored-to-go-on-sale-in-july/\" target=\"_blank\">expected to launch</a> this summer, and could be <a href=\"https://seekingalpha.com/currents/post/923501\" target=\"_blank\">aggressively priced</a>.</p><div class=\"tiny-share-widget\" data-id=\"1063231\" data-linked=\"InvenSense (INVN +5.6%) jumps after Maxim reports the company has scored a motion sensor design...\" data-tweet=\"$INVN - InvenSense (INVN +5.6%) jumps after Maxim reports the company has scored a motion sensor design win for the next version of Google&#39;s Nexus 7 - the current model also uses an InvenSense sensor chip. The next-gen 7 is expected to launch this summe... https://seekingalpha.com/news/1063231?source=tweet\" data-url=\"https://seekingalpha.com/news/1063231\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063221\" data-ts=\"1370359657\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063221\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham &amp;amp; Co. analyst Chad Messer thinks Isis Pharmaceuticals (ISIS +2.2%) can go 20% higher...</a></h4><p>Needham &amp; Co. analyst Chad Messer thinks Isis Pharmaceuticals (ISIS <font color=\"green\">+2.2%</font>) <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Upbeat+on+ISIS+Pharmaceuticals+%28ISIS%29+Following+ASCO/8387985.html\">can go 20% higher</a> from current levels. Messer likes the progress on ISIS-STAT3Rx and says recent developments with partner AstraZeneca \"help establish ISIS as an up-and-coming cancer player.\" (Previous: ISIS <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1060671\">earns milestone payment</a> from AZN)</p><div class=\"tiny-share-widget\" data-id=\"1063221\" data-linked=\"Needham &amp;amp; Co. analyst Chad Messer thinks Isis Pharmaceuticals (ISIS +2.2%) can go 20% higher...\" data-tweet=\"$IONS - Needham &amp; Co. analyst Chad Messer thinks Isis Pharmaceuticals (ISIS +2.2%) can go 20% higher from current levels. Messer likes the progress on ISIS-STAT3Rx and says recent developments with partner AstraZeneca &quot;help establish ISIS as an up-and-c... https://seekingalpha.com/news/1063221?source=tweet\" data-url=\"https://seekingalpha.com/news/1063221\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063181\" data-ts=\"1370358983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSII\" target=\"_blank\">HSII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063181\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heidrick &amp;amp; Struggles (HSII +2.4%) jumps after confirming reports that it has been approached...</a></h4><p>Heidrick &amp; Struggles (<a href=\"https://seekingalpha.com/symbol/HSII\" title=\"Heidrick &amp; Struggles International, Inc.\">HSII</a> <font color=\"green\">+2.4%</font>) jumps after confirming reports that it has been approached regarding a possible sale of the company. As a result of the overture, HSII's board will now review strategic alternatives. The shares are up <font color=\"green\">23%</font> since spiking at around 2:00 Monday afternoon. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1063181\" data-linked=\"Heidrick &amp;amp; Struggles (HSII +2.4%) jumps after confirming reports that it has been approached...\" data-tweet=\"$HSII - Heidrick &amp; Struggles (HSII +2.4%) jumps after confirming reports that it has been approached regarding a possible sale of the company. As a result of the overture, HSII&#39;s board will now review strategic alternatives. The shares are up 23% since ... https://seekingalpha.com/news/1063181?source=tweet\" data-url=\"https://seekingalpha.com/news/1063181\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063171\" data-ts=\"1370358760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGDX\" target=\"_blank\">RGDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063171\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Response Genetics (OTC:RGDX -2.7%) says it&#39;s reached its second milestone payment hurdle in...</a></h4><p>Response Genetics (<a href=\"https://seekingalpha.com/symbol/RGDX\" title=\"Response Genetics, Inc.\">OTC:RGDX</a> <font color=\"red\">-2.7%</font>) says it's reached its second milestone payment hurdle in conjunction with a licensing agreement with GlaxoSmithKline (NYSE:<a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a>) signed in 2010 to develop its BRAF-Inhibitor Tafinlar. Under the terms of the agreement, <a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a> gained certain rights to Response Genetics' proprietary PCR analysis technology and diagnostic expertise which received premarket approval from the FDA in May.</p><div class=\"tiny-share-widget\" data-id=\"1063171\" data-linked=\"Response Genetics (OTC:RGDX -2.7%) says it&#39;s reached its second milestone payment hurdle in...\" data-tweet=\"$RGDX $RGDX $GSK - Response Genetics (OTC:RGDX -2.7%) says it&#39;s reached its second milestone payment hurdle in conjunction with a licensing agreement with GlaxoSmithKline (NYSE:GSK) signed in 2010 to develop its BRAF-Inhibitor Tafinlar. Under the terms ... https://seekingalpha.com/news/1063171?source=tweet\" data-url=\"https://seekingalpha.com/news/1063171\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063151\" data-ts=\"1370358468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABM\" target=\"_blank\">ABM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063151\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ABM Industries (ABM +2.4%) enjoys a strong session after FQ2 earnings come in ahead of...</a></h4><p>ABM Industries (<a href=\"https://seekingalpha.com/symbol/ABM\" title=\"ABM Industries Incorporated\">ABM</a> <font color=\"green\">+2.4%</font>) enjoys a strong session after <a href=\"https://seekingalpha.com/currents/post/1061521\" target=\"_blank\">FQ2 earnings</a> come in ahead of expectations. From the report: Adjusted EPS rises 20% Y/Y as the janitorial, facility services, and security segments see organic growth of 2.7%, 8.4%, and 3% respectively. CEO Henrik Slipsager says \"recent project wins, a strong sales pipeline, and an improving economy, [leave ABM] well positioned for sustained growth.\" The company ups its full year EPS guidance to $1.40-1.50 versus consensus of $1.40. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1063151\" data-linked=\"ABM Industries (ABM +2.4%) enjoys a strong session after FQ2 earnings come in ahead of...\" data-tweet=\"$ABM - ABM Industries (ABM +2.4%) enjoys a strong session after FQ2 earnings come in ahead of expectations. From the report: Adjusted EPS rises 20% Y/Y as the janitorial, facility services, and security segments see organic growth of 2.7%, 8.4%, and 3% ... https://seekingalpha.com/news/1063151?source=tweet\" data-url=\"https://seekingalpha.com/news/1063151\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063081\" data-ts=\"1370357544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HE\" target=\"_blank\">HE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063081\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hawaiian Electric (HE -2.5%) slips this morning after lowering its FY13 EPS guidance to $1.52 -...</a></h4><p>Hawaiian Electric (<a href=\"https://seekingalpha.com/symbol/HE\" title=\"Hawaiian Electric Industries Inc.\">HE</a> <font color=\"red\">-2.5%</font>) slips this morning after lowering its FY13 EPS guidance to $1.52 - $1.62, from its previous range of $1.58 - $1.68. Analysts were expecting an EPS of $1.64. The company cites the final rate case decision and order issued by the Hawaiian Public Utilities Commission in May as the reason for the cut, which translates into $7.8M lower MECO annual revenues.</p><div class=\"tiny-share-widget\" data-id=\"1063081\" data-linked=\"Hawaiian Electric (HE -2.5%) slips this morning after lowering its FY13 EPS guidance to $1.52 -...\" data-tweet=\"$HE - Hawaiian Electric (HE -2.5%) slips this morning after lowering its FY13 EPS guidance to $1.52 - $1.62, from its previous range of $1.58 - $1.68. Analysts were expecting an EPS of $1.64. The company cites the final rate case decision and order issu... https://seekingalpha.com/news/1063081?source=tweet\" data-url=\"https://seekingalpha.com/news/1063081\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063031\" data-ts=\"1370355977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MKTO\" target=\"_blank\">MKTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063031\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marketo (MKTO -10.5%) gives back its early gains, and then some, as investors decide the...</a></h4><p>Marketo (<a href=\"https://seekingalpha.com/symbol/MKTO\" title=\"Marketo\">MKTO</a> <font color=\"red\">-10.5%</font>) gives back its early gains, and then some, as investors decide the <a href=\"https://seekingalpha.com/currents/post/1062211\" target=\"_blank\">Salesforce-ExactTarget deal</a> is bad news if a suitor doesn't come knocking. Roth points out Marketo gets 90% of its revenue from Salesforce's customer base, and thinks Salesforce's purchase of a rival could cause \"medium-term problems.\" Also: <a href=\"https://seekingalpha.com/currents/post/731931\" target=\"_blank\">many thought</a> Marketo, rather than ExactTarget, would be the cloud marketing automation firm Salesforce would go after. Responsys (<a href=\"https://seekingalpha.com/symbol/MKTG\" title=\"Responsys\">MKTG</a> <font color=\"green\">+7.5%</font>) remains sharply higher.</p><div class=\"tiny-share-widget\" data-id=\"1063031\" data-linked=\"Marketo (MKTO -10.5%) gives back its early gains, and then some, as investors decide the...\" data-tweet=\"$MKTO $MKTO $MKTG - Marketo (MKTO -10.5%) gives back its early gains, and then some, as investors decide the Salesforce-ExactTarget deal is bad news if a suitor doesn&#39;t come knocking. Roth points out Marketo gets 90% of its revenue from Salesforce&#39;s cus... https://seekingalpha.com/news/1063031?source=tweet\" data-url=\"https://seekingalpha.com/news/1063031\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1063021\" data-ts=\"1370355974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGT\" target=\"_blank\">MGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1063021\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MGT Capital Investments (MGT -3.3%) sells its portfolio of medical imaging patents to a major...</a></h4><p>MGT Capital Investments (<a href=\"https://seekingalpha.com/symbol/MGT\" title=\"MGT Capital Investments Inc\">MGT</a> <font color=\"red\">-3.3%</font>) sells its portfolio of medical imaging patents to a major Asian conglomerate for around $1.5M, thereby transitioning it to a company focused soley on internet and mobile gaming. The company expects to deploy the funds in the skill-based gaming space at present, while its board considers other avenues to enhance shareholder value.</p><div class=\"tiny-share-widget\" data-id=\"1063021\" data-linked=\"MGT Capital Investments (MGT -3.3%) sells its portfolio of medical imaging patents to a major...\" data-tweet=\"$MGT - MGT Capital Investments (MGT -3.3%) sells its portfolio of medical imaging patents to a major Asian conglomerate for around $1.5M, thereby transitioning it to a company focused soley on internet and mobile gaming. The company expects to deploy th... https://seekingalpha.com/news/1063021?source=tweet\" data-url=\"https://seekingalpha.com/news/1063021\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062961\" data-ts=\"1370355042\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GIII\" target=\"_blank\">GIII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062961\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of G-III Apparal (GIII +17.3%) are rip-roaring higher after the retailer puts in a strong...</a></h4><p>Shares of G-III Apparal (<a href=\"https://seekingalpha.com/symbol/GIII\" title=\"G-III Apparel Group, LTD.\">GIII</a> <font color=\"green\">+17.3%</font>) are rip-roaring higher after the retailer puts in a <a href=\"https://seekingalpha.com/currents/post/1061531\" target=\"_blank\">strong Q1</a> across product categories. A resurgence in the Calvin Klein brand helped boost results during the quarter.</p><div class=\"tiny-share-widget\" data-id=\"1062961\" data-linked=\"Shares of G-III Apparal (GIII +17.3%) are rip-roaring higher after the retailer puts in a strong...\" data-tweet=\"$GIII - Shares of G-III Apparal (GIII +17.3%) are rip-roaring higher after the retailer puts in a strong Q1 across product categories. A resurgence in the Calvin Klein brand helped boost results during the quarter. https://seekingalpha.com/news/1062961?source=tweet\" data-url=\"https://seekingalpha.com/news/1062961\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062941\" data-ts=\"1370354642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XSPA\" target=\"_blank\">XSPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062941\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vringo (VRNG -2.8%), VirnetX (VHC -4.5%), Acacia (ACTG -7.7%), Wi-Lan (WILN -2.2%), and RPX...</a></h4><p>Vringo (VRNG <font color=\"red\">-2.8%</font>), VirnetX (<a href=\"https://seekingalpha.com/symbol/VHC\" title=\"VirnetX Holding Corporation\">VHC</a> <font color=\"red\">-4.5%</font>), Acacia (<a href=\"https://seekingalpha.com/symbol/ACTG\" title=\"Acacia Research Corporation\">ACTG</a> <font color=\"red\">-7.7%</font>), Wi-Lan (WILN <font color=\"red\">-2.2%</font>), and RPX (<a href=\"https://seekingalpha.com/symbol/RPXC\" title=\"RPX Corporation\">RPXC</a> <font color=\"red\">-1.8%</font>) slide after the <em>WSJ</em> reports Pres. Obama is <a href=\"https://seekingalpha.com/currents/post/1062001\" target=\"_blank\">expected to announce</a> 5 executive actions and 7 legislative proposals taking aim at perceived patent trolls, <a href=\"http://online.wsj.com/article/SB10001424127887324563004578524182593163220.html\" target=\"_blank\">including</a> legislation enabling sanctions against litigants filing lawsuits deemed abusive, and orders to the USPTO to \"train examiners to scrutinize applications for overly broad patent claims.\" The report follow <a href=\"https://seekingalpha.com/currents/post/832011\" target=\"_blank\">harsh Feb. remarks</a> from Obama about patent trolls, as well as recent <a href=\"https://seekingalpha.com/currents/post/678091\" target=\"_blank\">DOJ/FTC hearings</a> regarding their activity.</p><div class=\"tiny-share-widget\" data-id=\"1062941\" data-linked=\"Vringo (VRNG -2.8%), VirnetX (VHC -4.5%), Acacia (ACTG -7.7%), Wi-Lan (WILN -2.2%), and RPX...\" data-tweet=\"$XSPA $XSPA $VHC - Vringo (VRNG -2.8%), VirnetX (VHC -4.5%), Acacia (ACTG -7.7%), Wi-Lan (WILN -2.2%), and RPX (RPXC -1.8%) slide after the WSJ reports Pres. Obama is expected to announce 5 executive actions and 7 legislative proposals taking aim at per... https://seekingalpha.com/news/1062941?source=tweet\" data-url=\"https://seekingalpha.com/news/1062941\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062921\" data-ts=\"1370354425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTCT\" target=\"_blank\">CTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062921\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloud fever: Shares of Constact Contact (CTCT +3.7%) are also getting pushed higher on optimism...</a></h4><p>Cloud fever: Shares of Constact Contact (<a href=\"https://seekingalpha.com/symbol/CTCT\" title=\"Constant Contact, Inc.\">CTCT</a> <font color=\"green\">+3.7%</font>) are also getting pushed higher on <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1062691\">optimism in the sector</a> after Salesforce paid a sweet premium for ExactTarget.</p><div class=\"tiny-share-widget\" data-id=\"1062921\" data-linked=\"Cloud fever: Shares of Constact Contact (CTCT +3.7%) are also getting pushed higher on optimism...\" data-tweet=\"$CTCT - Cloud fever: Shares of Constact Contact (CTCT +3.7%) are also getting pushed higher on optimism in the sector after Salesforce paid a sweet premium for ExactTarget. https://seekingalpha.com/news/1062921?source=tweet\" data-url=\"https://seekingalpha.com/news/1062921\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062911\" data-ts=\"1370354364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBOT\" target=\"_blank\">MBOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062911\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">StemCells (STEM +3.9% to $1.85) agrees to a $30M financing deal with Chicago-based Lincoln Park...</a></h4><p>StemCells (STEM <font color=\"green\">+3.9%</font> to $1.85) agrees to a $30M financing deal with Chicago-based Lincoln Park in which the latter will buy $3M worth of StemCells' stock immediately at $1.823 each and another $27M over the next three years. StemCells will control the timing of any future transactions and is not obligated to sell the shares, although Lincoln will be obligated to buy them. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1062911\" data-linked=\"StemCells (STEM +3.9% to $1.85) agrees to a $30M financing deal with Chicago-based Lincoln Park...\" data-tweet=\"$MBOT - StemCells (STEM +3.9% to $1.85) agrees to a $30M financing deal with Chicago-based Lincoln Park in which the latter will buy $3M worth of StemCells&#39; stock immediately at $1.823 each and another $27M over the next three years. StemCells will cont... https://seekingalpha.com/news/1062911?source=tweet\" data-url=\"https://seekingalpha.com/news/1062911\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062891\" data-ts=\"1370353939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTI\" target=\"_blank\">PSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pluristem Therapeutics (NASDAQ:PSTI) resumes trading 14.4% lower after shares were halted...</a></h4>Pluristem Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PSTI' title='Pluristem Therapeutics, Inc.'>PSTI</a>) resumes trading <font color=\"red\">14.4% lower</font> after shares were halted following news that the FDA has <a href=\"https://seekingalpha.com/currents/post/1062791\" target=\"_blank\">suspended the Phase II trials</a> for the company's placenta-based cell treatment for artery disease.<div class=\"tiny-share-widget\" data-id=\"1062891\" data-linked=\"Pluristem Therapeutics (NASDAQ:PSTI) resumes trading 14.4% lower after shares were halted...\" data-tweet=\"$PSTI - Pluristem Therapeutics (NASDAQ:PSTI) resumes trading 14.4% lower after shares were halted following news that the FDA has suspended the Phase II trials for the company&#39;s placenta-based cell treatment for artery disease. https://seekingalpha.com/news/1062891?source=tweet\" data-url=\"https://seekingalpha.com/news/1062891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062861\" data-ts=\"1370353555\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XRDC\" target=\"_blank\">XRDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062861\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Keating Capital (KIPO +7.8%) opens sharply higher after CEO Tim Keating takes to Seeking Alpha...</a></h4>Keating Capital (KIPO <font color=\"green\">+7.8%</font>) opens sharply higher after CEO Tim Keating <a href=\"https://seekingalpha.com/currents/post/1062301\" target=\"_blank\">takes to Seeking Alpha </a>to defend the stock in response to another SA contributor calling the shares a short.<div class=\"tiny-share-widget\" data-id=\"1062861\" data-linked=\"Keating Capital (KIPO +7.8%) opens sharply higher after CEO Tim Keating takes to Seeking Alpha...\" data-tweet=\"$XRDC - Keating Capital (KIPO +7.8%) opens sharply higher after CEO Tim Keating takes to Seeking Alpha to defend the stock in response to another SA contributor calling the shares a short. https://seekingalpha.com/news/1062861?source=tweet\" data-url=\"https://seekingalpha.com/news/1062861\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062841\" data-ts=\"1370353240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIOM\" target=\"_blank\">RIOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062841\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rio Alto Mining (RIOM -4.1%) temporarily suspends mining activities at its La Arena Gold Oxide...</a></h4><p>Rio Alto Mining (<a href=\"https://seekingalpha.com/symbol/RIOM\" title=\"Rio Alto Mining Ltd\">RIOM</a> <font color=\"red\">-4.1%</font>) temporarily <a href=\"http://finance.yahoo.com/news/rio-alto-mining-limited-mining-230335996.html\" target=\"_blank\">suspends mining activities</a> at its La Arena Gold Oxide Mine in Peru due to a blockade of the Trujillo to Huamachuco public road, the main access route for people and supplies. RIOM says 2013 total gold production may be negatively impacted due to the situation.</p><div class=\"tiny-share-widget\" data-id=\"1062841\" data-linked=\"Rio Alto Mining (RIOM -4.1%) temporarily suspends mining activities at its La Arena Gold Oxide...\" data-tweet=\"$RIOM - Rio Alto Mining (RIOM -4.1%) temporarily suspends mining activities at its La Arena Gold Oxide Mine in Peru due to a blockade of the Trujillo to Huamachuco public road, the main access route for people and supplies. RIOM says 2013 total gold pro... https://seekingalpha.com/news/1062841?source=tweet\" data-url=\"https://seekingalpha.com/news/1062841\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062821\" data-ts=\"1370352961\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Monster Beverage (MNST +4.2%) rally after Goldman Sachs issues a note to clients...</a></h4>Shares of Monster Beverage (<a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corp.'>MNST</a> <font color='green'>+4.2%</font>) rally after Goldman Sachs issues a note to clients indicating that the firm's sales <a href=\"https://twitter.com/SquawkStreet/status/341908640640401409\" target=\"_blank\">accelerated</a> in May.<div class=\"tiny-share-widget\" data-id=\"1062821\" data-linked=\"Shares of Monster Beverage (MNST +4.2%) rally after Goldman Sachs issues a note to clients...\" data-tweet=\"$MNST - Shares of Monster Beverage (MNST +4.2%) rally after Goldman Sachs issues a note to clients indicating that the firm&#39;s sales accelerated in May. https://seekingalpha.com/news/1062821?source=tweet\" data-url=\"https://seekingalpha.com/news/1062821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062791\" data-ts=\"1370352693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTI\" target=\"_blank\">PSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062791\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pluristem Therapeutics&#39;s (NASDAQ:PSTI) shares are halted after it says that the FDA has...</a></h4><p>Pluristem Therapeutics's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PSTI\" title=\"Pluristem Therapeutics, Inc.\">PSTI</a>) shares are halted after it says that the FDA has suspended the Phase II trial of the company's placenta-based cell treatment for artery disease following \"a serious allergic reaction\" that caused the patient to be hospitalized. The patient has multiple diseases, \"which may have influenced the severity of the event,\" and was discharged from hospital the following day. Shares are due to resume trading at 9:45. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1062791\" data-linked=\"Pluristem Therapeutics&#39;s (NASDAQ:PSTI) shares are halted after it says that the FDA has...\" data-tweet=\"$PSTI - Pluristem Therapeutics&#39;s (NASDAQ:PSTI) shares are halted after it says that the FDA has suspended the Phase II trial of the company&#39;s placenta-based cell treatment for artery disease following &quot;a serious allergic reaction&quot; that caused the patien... https://seekingalpha.com/news/1062791?source=tweet\" data-url=\"https://seekingalpha.com/news/1062791\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062771\" data-ts=\"1370352570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CP\" target=\"_blank\">CP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062771\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bill Ackman&#39;s decision to sell a 30% chunk of his Canadian Pacific (NYSE:CP) holdings triggers a...</a></h4><p>Bill Ackman's <a href=\"https://seekingalpha.com/currents/post/1061551\" target=\"_blank\">decision to sell</a> a 30% chunk of his Canadian Pacific (NYSE:<a href=\"https://seekingalpha.com/symbol/CP\" title=\"Canadian Pacific Railway Limited\">CP</a>) holdings triggers a <a href=\"http://business.financialpost.com/2013/06/04/cp-rail-downgraded-on-pershing-square-share-sale/\" target=\"_blank\">downgrade</a> from RBC, which thinks the sale may mark a shift to longer-term shareholders from momentum-driven catalyst investors. The firm says CP shares are pricing in a level of earnings growth that exceeds long-term financial targets, implying a fundamental share value 10%-30% below current levels. CP <font color=\"red\">-4.1%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1062771\" data-linked=\"Bill Ackman&#39;s decision to sell a 30% chunk of his Canadian Pacific (NYSE:CP) holdings triggers a...\" data-tweet=\"$CP - Bill Ackman&#39;s decision to sell a 30% chunk of his Canadian Pacific (NYSE:CP) holdings triggers a downgrade from RBC, which thinks the sale may mark a shift to longer-term shareholders from momentum-driven catalyst investors. The firm says CP share... https://seekingalpha.com/news/1062771?source=tweet\" data-url=\"https://seekingalpha.com/news/1062771\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062711\" data-ts=\"1370351878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROSG-OLD\" target=\"_blank\">ROSG-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062711\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rosetta Genomics (NASDAQ:ROSG-OLD), which recently signed its first U.S. PPO agreement, rises...</a></h4><p>Rosetta Genomics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ROSG-OLD\" title=\"Rosetta Genomics Ltd.\">ROSG-OLD</a>), which <a href=\"https://seekingalpha.com/currents/post/1034831\" target=\"_blank\">recently signed</a> its first U.S. PPO agreement, rises <font color=\"green\">6.5%</font> premarket after saying it is expanding its sales presence in the U.S. to 12 territories from five. The company also says its miRview test \"has been trending positively for the past three months in terms of samples processed and samples billed.\" (PR)</p><div class=\"tiny-share-widget\" data-id=\"1062711\" data-linked=\"Rosetta Genomics (NASDAQ:ROSG-OLD), which recently signed its first U.S. PPO agreement, rises...\" data-tweet=\"$ROSG-OLD - Rosetta Genomics (NASDAQ:ROSG-OLD), which recently signed its first U.S. PPO agreement, rises 6.5% premarket after saying it is expanding its sales presence in the U.S. to 12 territories from five. The company also says its miRview test &quot;has... https://seekingalpha.com/news/1062711?source=tweet\" data-url=\"https://seekingalpha.com/news/1062711\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062701\" data-ts=\"1370351713\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062701\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Market preview: U.S. stock futures gain a firmer hold in the green after fluttering around the...</a></h4><b>Market preview:</b> <a target=\"_blank\" href=\"http://www.reuters.com/article/2013/06/04/markets-usa-stocks-idUSL1N0EG0CX20130604\">U.S. stock futures</a> gain a firmer hold in the green after fluttering around the zero mark earlier and following a slightly lower-than-expected <a href=\"https://seekingalpha.com/currents/post/1062481\" target=\"_blank\">trade deficit</a>. The S&amp;P Mini is <font color=\"green\">+0.1%</font>. With a number of Fed policy makers set to speak today, things could get jumpy later as the market tries to discern what it means for QE. Salesforce <font color=\"red\">-4%</font> after saying it <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1062211\">will buy</a> ExactTarget (<font color=\"green\">+53%</font>) for $2.5B.<div class=\"tiny-share-widget\" data-id=\"1062701\" data-linked=\"Market preview: U.S. stock futures gain a firmer hold in the green after fluttering around the...\" data-tweet=\"Market preview: U.S. stock futures gain a firmer hold in the green after fluttering around the zero mark earlier and following a slightly lower-than-expected trade deficit. The S&amp;P Mini is +0.1%. With a number of Fed policy makers set to speak today, th... https://seekingalpha.com/news/1062701?source=tweet\" data-url=\"https://seekingalpha.com/news/1062701\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062691\" data-ts=\"1370351669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MKTG\" target=\"_blank\">MKTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062691\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Responsys (NASDAQ:MKTG) +10.5% and Marketo (NASDAQ:MKTO) +5.7% following news Salesforce...</a></h4><p>Responsys (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MKTG\" title=\"Responsys\">MKTG</a>) <font color=\"green\">+10.5%</font> and Marketo (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MKTO\" title=\"Marketo\">MKTO</a>) <font color=\"green\">+5.7%</font> following news Salesforce (NYSE:<a href=\"https://seekingalpha.com/symbol/CRM\" title=\"Salesforce.com, Inc.\">CRM</a>) is <a href=\"https://seekingalpha.com/currents/post/1062211\" target=\"_blank\">buying</a> cloud marketing automation software rival ExactTarget for $2.5B (a 53% premium). Salesforce <a href=\"https://seekingalpha.com/currents/post/731931\" target=\"_blank\">has long been expected</a> to make a cloud marketing acquisition following Oracle's purchase of <a href=\"https://seekingalpha.com/currents/post/730191\" target=\"_blank\">Eloqua</a>, and the deal might pressure rivals (Microsoft? SAP?) to make a similar move. Salesforce promises to add ExactTarget's software to its Marketing Cloud platform, which includes social media marketing software from the Buddy Media and Radian6 acquisitions, as well as the <a href=\"https://seekingalpha.com/currents/post/960451\" target=\"_blank\">Social.com app</a>.</p><div class=\"tiny-share-widget\" data-id=\"1062691\" data-linked=\"Responsys (NASDAQ:MKTG) +10.5% and Marketo (NASDAQ:MKTO) +5.7% following news Salesforce...\" data-tweet=\"$MKTG $MKTG $MKTO - Responsys (NASDAQ:MKTG) +10.5% and Marketo (NASDAQ:MKTO) +5.7% following news Salesforce (NYSE:CRM) is buying cloud marketing automation software rival ExactTarget for $2.5B (a 53% premium). Salesforce has long been expected to make ... https://seekingalpha.com/news/1062691?source=tweet\" data-url=\"https://seekingalpha.com/news/1062691\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062681\" data-ts=\"1370351519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ET-OLD\" target=\"_blank\">ET-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062681\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: ET-OLD +53%. MHGC +18%. INFI +9%. MFG +9%. MKTG +9%. SMFG +8%. NMR +8%. MTU...</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/ET-OLD\" title=\"Energy Transfer LP\">ET-OLD</a> <font color=\"green\">+53%</font>. <a href=\"https://seekingalpha.com/symbol/MHGC\" title=\"Morgans Hotel Group Co.\">MHGC</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/INFI\" title=\"Infinity Pharmaceuticals, Inc.\">INFI</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/MFG\" title=\"Mizuho Financial Group, Inc.\">MFG</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/MKTG\" title=\"Responsys\">MKTG</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/SMFG\" title=\"Sumitomo Mitsui Financial Group, Inc.\">SMFG</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/NMR\" title=\"Nomura Holdings, Inc.\">NMR</a> <font color=\"green\">+8%</font>. MTU <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/FCEL\" title=\"FuelCell Energy, Inc.\">FCEL</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/MCHP\" title=\"Microchip Technology Incorporated\">MCHP</a> <font color=\"green\">+5%</font>. <br><b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/RIGL\" title=\"Rigel Pharmaceuticals, Inc.\">RIGL</a> <font color=\"red\">-23%</font>. <a href=\"https://seekingalpha.com/symbol/DG\" title=\"Dollar General Corporation\">DG</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/SLCA\" title=\"U.S. Silica\">SLCA</a> <font color=\"red\">-6%</font>.<div class=\"tiny-share-widget\" data-id=\"1062681\" data-linked=\"Premarket gainers: ET-OLD +53%. MHGC +18%. INFI +9%. MFG +9%. MKTG +9%. SMFG +8%. NMR +8%. MTU...\" data-tweet=\"$ET-OLD $ET-OLD $MHGC - Premarket gainers: ET-OLD +53%. MHGC +18%. INFI +9%. MFG +9%. MKTG +9%. SMFG +8%. NMR +8%. MTU +7%. FCEL +6%. MCHP +5%. Losers: RIGL -23%. DG -7%. SLCA -6%. https://seekingalpha.com/news/1062681?source=tweet\" data-url=\"https://seekingalpha.com/news/1062681\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062631\" data-ts=\"1370351017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFI\" target=\"_blank\">INFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062631\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinity Pharmaceuticals (NASDAQ:INFI) +10.3% to $18.10 after collapsing 39% yesterday following...</a></h4><p>Infinity Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/INFI\" title=\"Infinity Pharmaceuticals, Inc.\">INFI</a>) <font color=\"green\">+10.3%</font> to $18.10 after collapsing 39% yesterday following its presentation for its IPI-145 leukemia treatment, with Wells Fargo, RBC and Piper <a target=\"_blank\" href=\"https://twitter.com/search?q=%24INFI%20%40thenotablecalls&amp;src=typd\">jumping</a> to the company's defense. RBC believes that IPI-145 <a target=\"_blank\" href=\"http://www.prcarbon.com/press/biotech-most-active-stocks-affymax-mannkind-gilead-sciences-infinity-pharmaceuticals-halozyme-therapeutics-flamel-technologies-celsion-corporation-peregrine-pharmaceuticals-1005927.html\">can be better</a> than Gilead's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a>) product, while Piper says that the lymphoma data outshines competitors. The firm reckons that Infinity is too cheap and gives it a $50 price target.</p><div class=\"tiny-share-widget\" data-id=\"1062631\" data-linked=\"Infinity Pharmaceuticals (NASDAQ:INFI) +10.3% to $18.10 after collapsing 39% yesterday following...\" data-tweet=\"$INFI $INFI $GILD - Infinity Pharmaceuticals (NASDAQ:INFI) +10.3% to $18.10 after collapsing 39% yesterday following its presentation for its IPI-145 leukemia treatment, with Wells Fargo, RBC and Piper jumping to the company&#39;s defense. RBC believes that... https://seekingalpha.com/news/1062631?source=tweet\" data-url=\"https://seekingalpha.com/news/1062631\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062421\" data-ts=\"1370348321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062421\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Admitting what has become obvious, Barrick Gold (ABX) says completion of the Pascua-Lama project...</a></h4><p>Admitting what has become obvious, Barrick Gold (ABX) says completion of the <a href=\"https://seekingalpha.com/currents/search?query=pascua-lama\" target=\"_blank\">Pascua-Lama</a> project <a href=\"http://business.financialpost.com/2013/06/03/barrick-says-pascua-lama-project-in-chile-delayed-beyond-2014/\" target=\"_blank\">will be delayed beyond 2014</a>, and capital costs likely will exceed its $8B-$8.5B estimate. ABX will \"evaluate all alternatives\" for Pascua-Lama in light of the current <a href=\"https://seekingalpha.com/currents/post/1046371\" target=\"_blank\">legal and regulatory issues</a>, but few expect it to give up totally on such an important part of its long-term future. ABX <font color=\"red\">-2.3%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1062421\" data-linked=\"Admitting what has become obvious, Barrick Gold (ABX) says completion of the Pascua-Lama project...\" data-tweet=\"$GOLD - Admitting what has become obvious, Barrick Gold (ABX) says completion of the Pascua-Lama project will be delayed beyond 2014, and capital costs likely will exceed its $8B-$8.5B estimate. ABX will &quot;evaluate all alternatives&quot; for Pascua-Lama in li... https://seekingalpha.com/news/1062421?source=tweet\" data-url=\"https://seekingalpha.com/news/1062421\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062361\" data-ts=\"1370347922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DG\" target=\"_blank\">DG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Though Dollar General (NYSE:DG) met estimates with its Q1 report, a cut in guidance is proving...</a></h4><p>Though Dollar General (NYSE:<a href=\"https://seekingalpha.com/symbol/DG\" title=\"Dollar General Corporation\">DG</a>) met estimates with its <a href=\"https://seekingalpha.com/currents/post/1062161\" target=\"_blank\">Q1 report</a>, a cut in guidance is proving painful as shares <font color=\"red\">slide 6.3%</font> premarket. Peers Family Dollar Stores (NYSE:<a href=\"https://seekingalpha.com/symbol/FDO\" title=\"Family Dollar Stores Inc.\">FDO</a>), Dollar Tree (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DLTR\" title=\"Dollar Tree, Inc.\">DLTR</a>), and Five Below (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FIVE\" title=\"Five Below\">FIVE</a>) are on watch with the outlook from Dollar General for soft sales of non-consumables likely to weigh on shares in the discounting sector.</p><div class=\"tiny-share-widget\" data-id=\"1062361\" data-linked=\"Though Dollar General (NYSE:DG) met estimates with its Q1 report, a cut in guidance is proving...\" data-tweet=\"$DG $DG $FDO - Though Dollar General (NYSE:DG) met estimates with its Q1 report, a cut in guidance is proving painful as shares slide 6.3% premarket. Peers Family Dollar Stores (NYSE:FDO), Dollar Tree (NASDAQ:DLTR), and Five Below (NASDAQ:FIVE) are on w... https://seekingalpha.com/news/1062361?source=tweet\" data-url=\"https://seekingalpha.com/news/1062361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062341\" data-ts=\"1370347564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TUR\" target=\"_blank\">TUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062341\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mercifully, Turkish stocks (TUR +3% premarket) recover from what can quite fairly be described...</a></h4><p>Mercifully, Turkish stocks (<a href=\"https://seekingalpha.com/symbol/TUR\" title=\"iShares MSCI Turkey ETF\">TUR</a> <font color=\"green\">+3%</font> premarket) recover from what can quite fairly be described as a crash Monday (<a href=\"https://seekingalpha.com/currents/post/1059651\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/1059201\" target=\"_blank\">II</a>). The Borsa Instanbul rises <font color=\"green\">5.2%</font>, even as CNN's Fadi Hakura asks: \"<a href=\"http://www.cnn.com/2013/06/03/opinion/turkey-protests-not-arab-spring/\" target=\"_blank\">Is Turkey on the verge of a meltdown?</a>\" (See also: \"<a href=\"https://seekingalpha.com/article/1478251-turkey-not-an-arab-spring-but-a-turkish-summer\" target=\"_blank\">A Turkish Spring?</a>\" from SA contributor Emerging Money and Tim Seymour)</p><div class=\"tiny-share-widget\" data-id=\"1062341\" data-linked=\"Mercifully, Turkish stocks (TUR +3% premarket) recover from what can quite fairly be described...\" data-tweet=\"$TUR - Mercifully, Turkish stocks (TUR +3% premarket) recover from what can quite fairly be described as a crash Monday (I, II). The Borsa Instanbul rises 5.2%, even as CNN&#39;s Fadi Hakura asks: &quot;Is Turkey on the verge of a meltdown?&quot; (See also: &quot;A Turkis... https://seekingalpha.com/news/1062341?source=tweet\" data-url=\"https://seekingalpha.com/news/1062341\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1062211\" data-ts=\"1370346151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1062211\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Salesforce.com (NYSE:CRM) purchases email marketing firm ExactTarget (NYSE:ET-OLD) for...</a></h4><p>Salesforce.com (NYSE:<a href=\"https://seekingalpha.com/symbol/CRM\" title=\"Salesforce.com, Inc.\">CRM</a>) purchases email marketing firm ExactTarget (NYSE:<a href=\"https://seekingalpha.com/symbol/ET-OLD\" title=\"Energy Transfer LP\">ET-OLD</a>) for $33.75/share in cash, a total transaction value of about $2.5B. Salesforce.com expects the purchase to reduce FY14 non-GAAP EPS by about $0.16. Assuming a late Q2 close, new EPS guidance for Q2 FY14 is $0.06-$0.07, and for FY14 of $0.31-$0.33 on revenue of $3.955B-$4B. ET <font color=\"green\">+51.8%</font> to $33.54 premarket, CRM <font color=\"green\">+3.3%</font>. <a href=\"http://www.salesforce.com/investor\" target=\"_blank\">CC</a> at 8 ET. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1062211\" data-linked=\"Salesforce.com (NYSE:CRM) purchases email marketing firm ExactTarget (NYSE:ET-OLD) for...\" data-tweet=\"$CRM $CRM $ET-OLD - Salesforce.com (NYSE:CRM) purchases email marketing firm ExactTarget (NYSE:ET-OLD) for $33.75/share in cash, a total transaction value of about $2.5B. Salesforce.com expects the purchase to reduce FY14 non-GAAP EPS by about $0.16. As... https://seekingalpha.com/news/1062211?source=tweet\" data-url=\"https://seekingalpha.com/news/1062211\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1061961\" data-ts=\"1370334788\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STM\" target=\"_blank\">STM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1061961\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">STMicroelectronics (NYSE:STM) rises 4.4% in Paris after CEO Carlo Bozotti tells Le Figaro that...</a></h4><p>STMicroelectronics (NYSE:<a href=\"https://seekingalpha.com/symbol/STM\" title=\"STMicroelectronics NV\">STM</a>) <font color=\"green\">rises 4.4%</font> in Paris after CEO Carlo Bozotti tells <em>Le Figaro</em> that he is <a href=\"http://www.lefigaro.fr/societes/2013/06/04/20005-20130604ARTFIG00296-stmicro-produire-en-europe-est-un-atout-competitif.php\" target=\"_blank\">targeting order growth</a> of 5-10% this year following an increase of 5% in Q1. The plan is to eventually achieve annual turnover of $9B (the figure was $8.49B in 2012). Bozotti notes that every 1% change in the euro-dollar rate \"has an impact of \u20ac35M on operating profit per year.\"</p><div class=\"tiny-share-widget\" data-id=\"1061961\" data-linked=\"STMicroelectronics (NYSE:STM) rises 4.4% in Paris after CEO Carlo Bozotti tells Le Figaro that...\" data-tweet=\"$STM - STMicroelectronics (NYSE:STM) rises 4.4% in Paris after CEO Carlo Bozotti tells Le Figaro that he is targeting order growth of 5-10% this year following an increase of 5% in Q1. The plan is to eventually achieve annual turnover of $9B (the figure... https://seekingalpha.com/news/1061961?source=tweet\" data-url=\"https://seekingalpha.com/news/1061961\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1061931\" data-ts=\"1370332238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1061931\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Nikkei continues its yo-yoing, jumping 2% today after its sharp fall yesterday and as the...</a></h4><p>The Nikkei <a href=\"http://www.reuters.com/article/2013/06/04/us-markets-global-idUSBRE88901C20130604\" target=\"_blank\">continues its yo-yoing</a>, <font color=\"green\">jumping 2%</font> today after its sharp fall yesterday and as the yen weakens against the dollar. The moves follow soft U.S. manufacturing data yesterday, which eased fears about the Fed's QE program and have also helped to boost European stocks in early trading. However, Chinese shares drop, partly due to investors <a href=\"http://www.businessweek.com/news/2013-06-03/china-s-stock-futures-fall-signaling-losses-for-benchmark-index\" target=\"_blank\">taking profits</a> on small-caps. Hong Kong flat, China <font color=\"red\">-1.2%</font>, India <font color=\"green\">+0.2%</font>. EU Stoxx 50 <font color=\"green\">+0.7%</font>, London <font color=\"green\">+0.5%</font>, Paris <font color=\"green\">+0.7%</font>, Frankfurt <font color=\"green\">+0.8%</font>, Madrid <font color=\"green\">+0.9%</font>, Milan <font color=\"green\">+1%</font>.</p><div class=\"tiny-share-widget\" data-id=\"1061931\" data-linked=\"The Nikkei continues its yo-yoing, jumping 2% today after its sharp fall yesterday and as the...\" data-tweet=\"The Nikkei continues its yo-yoing, jumping 2% today after its sharp fall yesterday and as the yen weakens against the dollar. The moves follow soft U.S. manufacturing data yesterday, which eased fears about the Fed&#39;s QE program and have also helped to b... https://seekingalpha.com/news/1061931?source=tweet\" data-url=\"https://seekingalpha.com/news/1061931\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 AM </div></div></li>","count":65,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}